並列摘要
Before any drug products are marketed, it is required by the government regulatory agencies that stability studies to be conducted. The objective of the stability studies is not only to characterize the degradation curve but also to estimate the shelf-life of the drug products. The estimated shelf-life gives a certain assurance that the drug products retains its identity, strength, quality and purity during the time period. In this paper, we give an overview of the stability studies, which includes the historical background, comparisons of guidelines among various countries, recent developments, as well as future research topics.
延伸閱讀
- Chow, S. C., & Pong, A. P. (1995). 藥物安定性規範之研究分析. 藥物食品分析, 3(2), 75-85. https://www.airitilibrary.com/Article/Detail?DocID=10219498-199507-3-2-75-85-a
- 朱蓁蓁、沈麗娟、何蘊芳、林慧玲（2009）。用藥安全推動成果與展望。醫療品質雜誌，3(2)，23-27。https://doi.org/10.30160/JHQ.200903.0006
- 張智欽（2016）。藥物濫用預警模型取樣與建置之研究〔碩士論文，國立中正大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0033-2110201614053422
- 呂秀英（1994）。A SAS Program for Regression Analysis of Stability。中華農業研究，43(3)，283-292。https://doi.org/10.29951/JARC.199409.0003
- (2004). Growth with Stability and Equity. In 國家發展委員會. (Ed.), Economic development, r.o.c (taiwan) (pp. 6-7). 國家發展委員會.. https://www.airitilibrary.com/Article/Detail?DocID=P20191031003-200405-201911040016-201911040016-6-7